Apple's China business accounted for more than 17% of its sales in its fiscal second quarter, coming in at $10.22 billion.Marketsread more
Qualcomm suppressed competition in the market for cellphone chips and used its position to impose excessive licensing fees, a U.S. judged ruled.Technologyread more
Morgan Stanley caused a stir with its "bear case" scenario of $10. Now, Citi is getting in on the act.Investingread more
China is considering cutting natural gas purchases from the U.S. in its tit-for-tat on trade, according to the South China Morning Post.Marketsread more
"I've had no conversations ever with the president or anyone in the White House about delivering the president's tax returns to Congress," Mnuchin said during a hearing before...Politicsread more
Treasury Secretary Steven Mnuchin is scheduled to testify before the House Financial Services Committee on Wednesday about the international financial system.Politicsread more
Homeowners are taking advantage of lower interest rates, rushing to refinance their mortgages before rates potentially turn higher again.Real Estateread more
If you beat the odds and nab the top Mega Millions prize, the IRS would get more than $58 million before the windfall reaches you. You also could count on owing more at tax...Personal Financeread more
If your Apple MacBook, MacBook Air or MacBook Pro isn't working right, Apple is fixing most of the models sold within the last four years for free. Here's how to get it fixed.Technologyread more
Treasury Secretary Steven Mnuchin said nothing is scheduled yet for the U.S. to go to Beijing for the next round of trade talks.Marketsread more
The high-end real estate market is suffering, with a glut of over-built and over-priced mansions in many of the country's most affluent ZIP codes.Wealthread more
AMSTERDAM, The Netherlands, May 27, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present a corporate overview at the Jefferies 2015 Global Healthcare Conference, to be held in New York City, June 1-4, 2015.
Date: June 1, 2015
Time: 10:00 a.m. (ET)
Speaking for uniQure: Matthew Kapusta, Chief Financial Officer
To access a simultaneous webcast of Mr. Kapusta's presentation via the internet, log on to the "Events" section on the Media page of the uniQure website at http://www.uniqure.com/news/calendar-of-events/.
A replay of the webcast will be available from uniQure's website for 90 days following the conference. Mr. Kapusta's presentation will be available for download in PDF format immediately following the conference presentation in the "Events" section of the Media page of uniQure's website at http://www.uniqure.com/news/calendar-of-events/.
uniQure is delivering on the promise of gene therapy through single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease-modifying therapies to patients with severe disorders. We are engaged in multiple partnerships and have obtained regulatory approval of our lead product, Glybera, in the European Union for a subset of patients with LPLD.
CONTACT: uniQure: Aicha Diba Investor Relations Direct: +31 20 240 6100 Main: +31 20 240 6000 a.diba@uniQure.com Media inquiries: Gretchen Schweitzer MacDougall Biomedical Communications Direct: +49 172 861 8540 Main: +49 89 2424 3494 or +1 781 235 3060 email@example.comSource: uniQure